CA-ADVA
10.3.2021 19:02:07 CET | Business Wire | Press release
ADVA (FSE: ADV) today announced that it has jointly won two awards at the MEF 3.0 Proof of Concept (PoC) Showcase. The honors recognize innovation and leadership with emerging services and technologies involving AI, SD-WAN, service automation and more. The Judge’s Choice Award for the best overall PoC was presented to a multi-vendor solution using ADVA’s Ensemble NFV suite to deliver personalized and automatically generated live video content over optimized network slices. Leveraging AI video technology and uCPE hosting SD-WAN, the demo showed how service providers can meet demand for unique immersive experiences of events such as live sports. ADVA also won the Market Game Changer Award, recognizing the largest potential impact on the service provider market. This was presented for its collaboration on a PoC using ADVA Ensemble software to enable multi-edge cloud services. This technology will be key to empowering enterprises to provide low-latency, high-throughput applications such as smart factories and industrial IoT.
“Our award-winning demo, Revolutionizing Live Events, illustrates how cable network operators can deliver exciting new services in an entirely original way. We’ve shown that it’s now possible to offer a unique, differentiated experience of live events that puts audiences at the heart of the action. Sports or music fans could soon be selecting their own viewing angles and receiving coverage that automatically zooms and tracks in real time. And for service providers, this points to a simple and cost-effective way of enabling high-volume, high-margin entertainment services,” said James Buchanan, GM, Edge Cloud, ADVA. “We’ve shown that utilizing uCPE and network slicing over enterprise networks can transform the way video content is produced and distributed. This cloud-based, virtualized approach opens the door to new levels of flexibility and automation for video services. What’s more, it highlights the potential of uCPE as a platform for innovation ready to unleash an array of new applications and business models.”
Featuring ADVA’s Ensemble suite of NFV software, the Revolutionizing Live Events PoC highlighted new opportunities for service providers to meet the growing expectations of sports and entertainment audiences. Driven by compute-based AI/ML, MEF-defined network slicing and lightweight uCPE running SD-WAN, the demo showed how network resources can be utilized to provide automated, highly personalized video content.
ADVA’s other award-winning PoC was the Orchestrated Multi-Edge Clouds demo. For this, the Ensemble NFV suite was deployed to manage and orchestrate SD-WAN, IoT, 5G networking and other edge-cloud technologies, seamlessly enabling the distribution of smart manufacturing resources between on-premises and network edge cloud environments. This demo paves the way for enterprises to purchase mission-critical applications and services flexibly and on demand.
“Our multi-edge cloud MEF 3.0 PoC is a key step in helping businesses to improve operational efficiency as they continue to digitize and automate their processes. It shows how service providers can accelerate adoption of multi-edge cloud services through the orchestration of applications and connectivity on open edge compute platforms. Winning the Market Game Changer Award underlines the impact on enterprises of being able to instantly purchase applications such as IoT, SD-WAN and wireless network access from a single managed service provider and have them automatically deployed across multiple cloud platforms,” commented Mike Heffner, VP, product line management, Edge Cloud, ADVA. “Using our Ensemble NFV software, this PoC proves that it’s now possible to relieve businesses of the responsibility and burden of multi-vendor system integration. This creates a major opportunity for service providers. They can offer on-demand, managed edge services and connectivity on open edge compute platforms that can be deployed in multiple locations. And, using advanced analytics, they can select the best edge location for IoT applications to meet SLAs.”
More information about the Revolutionizing Live Events PoC is available here: https://adva.li/mef-poc-live-events .
Further details on the Orchestrated Multi-Edge Clouds demo can be viewed here: https://adva.li/mef-poc-multi-edge-clouds .
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .
Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210310005482/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release
Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom